As Medical Instruments & Supplies businesses, Utah Medical Products Inc. (NASDAQ:UTMD) and Valeritas Holdings Inc. (NASDAQ:VLRX), are affected by contrast. This especially applies to their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership.

Earnings & Valuation

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products Inc.	42.00M	7.63	18.55M	4.10	21.42
Valeritas Holdings Inc.	26.40M	1.26	48.13M	-5.04	0.00

In table 1 we can see Utah Medical Products Inc. and Valeritas Holdings Inc.’s gross revenue, earnings per share and valuation.

Profitability

Table 2 represents Utah Medical Products Inc. (NASDAQ:UTMD) and Valeritas Holdings Inc. (NASDAQ:VLRX)’s net margins, return on assets and return on equity.

	Net Margins	Return on Equity	Return on Assets
Utah Medical Products Inc.	44.17%	11.4%	9.8%
Valeritas Holdings Inc.	-182.31%	885.5%	-116.4%

Liquidity

Utah Medical Products Inc.’s Current Ratio is 12.4 while its Quick Ratio is 11.3. On the competitive side is, Valeritas Holdings Inc. which has a 3 Current Ratio and a 2.5 Quick Ratio. Utah Medical Products Inc. is better positioned to pay off short and long-term obligations compared to Valeritas Holdings Inc.

Dividends

Utah Medical Products Inc. pays out an annual dividend of $1.09 per share while its dividend yield is 1.28%. Valeritas Holdings Inc. does not offer a dividend.

Institutional & Insider Ownership

Roughly 75.6% of Utah Medical Products Inc. shares are held by institutional investors while 73.3% of Valeritas Holdings Inc. are owned by institutional investors. Utah Medical Products Inc.’s share held by insiders are 0.6%. Competitively, insiders own roughly 0.4% of Valeritas Holdings Inc.’s shares.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
Utah Medical Products Inc.	-0.23%	-6.54%	-8.25%	-2.88%	0.29%	5.68%
Valeritas Holdings Inc.	7.87%	23.66%	31.69%	-57.03%	-82.64%	55.76%

For the past year Utah Medical Products Inc.’s stock price has smaller growth than Valeritas Holdings Inc.

Summary

Utah Medical Products Inc. beats on 10 of the 12 factors Valeritas Holdings Inc.

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. The company also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit. In addition, it provides LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes; other UTMD supplies and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; EPITOME, an electrosurgical scalpel; FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; holmium laser fibers; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Further, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. The company markets its products to neonatal intensive care unit, labor and delivery department, womenÂ’s health center in hospitals, outpatient clinics, and physician's offices. It sells its products through direct sales, independent manufacturerÂ’s representatives, distributors, national hospital distribution companies, other medical device manufacturers and companies, and independent medical product distributors. The company was founded in 1978 and is headquartered in Midvale, Utah.

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject, a disposable needle-free injection system that delivers drugs ranging from small molecules to large proteins, as well as antibodies and vaccines; and Micro-Trans microneedle array patch technology to deliver drugs into the dermis layer of the skin. In addition, its products include V-Go Prefill, which is in the design-development stage, for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go Link that is in the early stages of development for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors in the United States. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.